BOVILIS® CAVALRY® 9
Clostridium Chauvoei-Septicum-Haemolyticum-Novyi-Sordellii-Tetani-Perfringens Types C & D Bacterin-Toxoid
Product Description
Shown to be effective for the vaccination of healthy cattle 3 months of age or older against disease caused by Clostridium chauvoei, Cl. septicum, Cl. novyi Type B, Cl. haemolyticum, Cl. sordellii, Cl. tetani and Cl. perfringens Types C and D.
Indications
This product has been shown to be effective for the vaccination of healthy cattle against disease caused by Clostridium chauvoei, C. septicum, C. haemolyticum, C. novyi, C. sordellii, C. tetani, and C. perfringens Types C & D. This product was licensed prior to the requirement to establish a minimum age for use. Duration of immunity has not been established.
Although C. perfringens Type B is not a significant problem in North America, immunity is derived from a combination of the Type C (beta) and Type D (epsilon) fractions.
Diseases
- Clostridium sordellii
Dosage
Mix gently. Inject 2 mL subcutaneously followed by a 2 mL dose in 3 weeks. Calves vaccinated at 3-6 months of age should be given a 3rd vaccination with either this vaccine, or another vaccine containing C. perfringens Type D epsilon toxoid. For advice on revaccination frequency, contact your veterinarian.
Supplied
1 x 20 mL (10 doses)
1 x 100 mL (50 doses)
1 x 250 mL (125 doses)
Preservatives
Contains Gentamicin and thimerosal as preservatives.
Caution
Store at 2°-8°C (35°-46°F). Do not freeze. Use entire contents when first opened. Do not mix with other products. Do not vaccinate within 21 days before slaughter. This product has not been tested in pregnant animals. Anaphylactoid reactions may occur following use.
Antidote: Epinephrine. In case of human exposure, contact a physician.
FOR ANIMAL USE ONLY.
Contact
U.S. only: Merck Animal Health livestocktechsrvc@merck-animal-health.com or call 1-800-211-3573
For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov
For additional information, please see the product label.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global